“Economic Evaluation of Temsirolimus on the Basis of the Results of the ARCC (Advanced Renal-Cell Carcinoma) Study”. 2009. Farmeconomia. Health Economics and Therapeutic Pathways 10 (2): 93-97. https://doi.org/10.7175/fe.v10i2.167.